nodes	percent_of_prediction	percent_of_DWPC	metapath
Phendimetrazine—obesity—polycystic ovary syndrome	0.58	1	CtDrD
Phendimetrazine—ADRA1B—polycystic ovary syndrome	0.233	0.598	CbGaD
Phendimetrazine—ADRA1A—polycystic ovary syndrome	0.157	0.402	CbGaD
Phendimetrazine—ADRA1B—AMPK Signaling—AKT2—polycystic ovary syndrome	5.84e-05	0.00195	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	5.77e-05	0.00193	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—PTGER3—polycystic ovary syndrome	5.64e-05	0.00189	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—LHCGR—polycystic ovary syndrome	5.64e-05	0.00189	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	5.62e-05	0.00188	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	5.58e-05	0.00187	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	5.57e-05	0.00186	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	5.54e-05	0.00185	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	5.42e-05	0.00181	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	5.38e-05	0.0018	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—NRG1—polycystic ovary syndrome	5.32e-05	0.00178	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	5.31e-05	0.00177	CbGpPWpGaD
Phendimetrazine—ADRA1B—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	5.29e-05	0.00177	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—PTAFR—polycystic ovary syndrome	5.28e-05	0.00176	CbGpPWpGaD
Phendimetrazine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	5.26e-05	0.00176	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	5.19e-05	0.00173	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—AKT2—polycystic ovary syndrome	5.19e-05	0.00173	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	5.12e-05	0.00171	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	4.98e-05	0.00167	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	4.92e-05	0.00164	CbGpPWpGaD
Phendimetrazine—ADRA1B—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	4.87e-05	0.00163	CbGpPWpGaD
Phendimetrazine—SLC6A3—Neuronal System—CAMK2D—polycystic ovary syndrome	4.87e-05	0.00163	CbGpPWpGaD
Phendimetrazine—SLC6A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	4.82e-05	0.00161	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	4.77e-05	0.0016	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	4.75e-05	0.00159	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	4.74e-05	0.00158	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	4.72e-05	0.00158	CbGpPWpGaD
Phendimetrazine—ADRA1A—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	4.7e-05	0.00157	CbGpPWpGaD
Phendimetrazine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	4.67e-05	0.00156	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—FSHR—polycystic ovary syndrome	4.65e-05	0.00155	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	4.61e-05	0.00154	CbGpPWpGaD
Phendimetrazine—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	4.33e-05	0.00145	CbGpPWpGaD
Phendimetrazine—SLC6A3—Neuronal System—DLG4—polycystic ovary syndrome	4.31e-05	0.00144	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—NPB—polycystic ovary syndrome	4.3e-05	0.00144	CbGpPWpGaD
Phendimetrazine—SLC6A3—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	4.27e-05	0.00143	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	4.25e-05	0.00142	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	4.22e-05	0.00141	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	4.21e-05	0.00141	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—FSHR—polycystic ovary syndrome	4.13e-05	0.00138	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—ADRB3—polycystic ovary syndrome	4.09e-05	0.00137	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—LHB—polycystic ovary syndrome	4.04e-05	0.00135	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—GNRH1—polycystic ovary syndrome	3.95e-05	0.00132	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—NPB—polycystic ovary syndrome	3.91e-05	0.00131	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	3.89e-05	0.0013	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—NPB—polycystic ovary syndrome	3.82e-05	0.00128	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	3.81e-05	0.00127	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	3.81e-05	0.00127	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—SCT—polycystic ovary syndrome	3.79e-05	0.00127	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—ADRB3—polycystic ovary syndrome	3.64e-05	0.00121	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	3.62e-05	0.00121	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—LHB—polycystic ovary syndrome	3.59e-05	0.0012	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	3.59e-05	0.0012	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	3.59e-05	0.0012	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	3.53e-05	0.00118	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—GNRH1—polycystic ovary syndrome	3.51e-05	0.00117	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	3.51e-05	0.00117	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—NPB—polycystic ovary syndrome	3.47e-05	0.00116	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	3.46e-05	0.00115	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	3.39e-05	0.00113	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	3.38e-05	0.00113	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	3.38e-05	0.00113	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—SCT—polycystic ovary syndrome	3.37e-05	0.00112	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	3.36e-05	0.00112	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PTGER3—polycystic ovary syndrome	3.26e-05	0.00109	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—LHCGR—polycystic ovary syndrome	3.26e-05	0.00109	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	3.26e-05	0.00109	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	3.21e-05	0.00107	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	3.19e-05	0.00107	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	3.19e-05	0.00107	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	3.14e-05	0.00105	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	3.11e-05	0.00104	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PTAFR—polycystic ovary syndrome	3.05e-05	0.00102	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	3.01e-05	0.00101	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	2.98e-05	0.000997	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	2.96e-05	0.000989	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	2.9e-05	0.00097	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	2.9e-05	0.000968	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	2.9e-05	0.000968	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	2.9e-05	0.000968	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	2.88e-05	0.000964	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.88e-05	0.000963	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	2.82e-05	0.000941	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	2.71e-05	0.000905	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.68e-05	0.000895	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—GHRL—polycystic ovary syndrome	2.67e-05	0.000892	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FLT4—polycystic ovary syndrome	2.64e-05	0.000882	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	2.63e-05	0.000879	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—FSHR—polycystic ovary syndrome	2.63e-05	0.000878	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PDE3B—polycystic ovary syndrome	2.62e-05	0.000875	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	2.58e-05	0.000862	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	2.56e-05	0.000856	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	2.56e-05	0.000855	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.55e-05	0.000853	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.45e-05	0.000819	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	2.4e-05	0.000803	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—FSHR—polycystic ovary syndrome	2.39e-05	0.000797	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.37e-05	0.000793	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—GHRL—polycystic ovary syndrome	2.37e-05	0.000793	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FLT4—polycystic ovary syndrome	2.34e-05	0.000784	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	2.33e-05	0.00078	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	2.33e-05	0.000778	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	2.31e-05	0.000773	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NPB—polycystic ovary syndrome	2.31e-05	0.000771	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—LHB—polycystic ovary syndrome	2.29e-05	0.000764	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	2.23e-05	0.000747	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—ADRB2—polycystic ovary syndrome	2.21e-05	0.000739	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	2.18e-05	0.000729	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.17e-05	0.000725	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—SCT—polycystic ovary syndrome	2.14e-05	0.000716	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	2.12e-05	0.000708	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—ADRB3—polycystic ovary syndrome	2.1e-05	0.000702	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	2.09e-05	0.000697	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—LHB—polycystic ovary syndrome	2.08e-05	0.000694	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.06e-05	0.000687	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	2.05e-05	0.000687	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—GNAS—polycystic ovary syndrome	2.05e-05	0.000685	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NPB—polycystic ovary syndrome	2.05e-05	0.000685	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	2.04e-05	0.000683	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	2.03e-05	0.000678	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—GNRH1—polycystic ovary syndrome	2.03e-05	0.000678	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	1.98e-05	0.000663	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	1.96e-05	0.000656	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—SCT—polycystic ovary syndrome	1.95e-05	0.00065	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTGER3—polycystic ovary syndrome	1.93e-05	0.000644	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LHCGR—polycystic ovary syndrome	1.93e-05	0.000644	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	1.9e-05	0.000636	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	1.87e-05	0.000624	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	1.86e-05	0.00062	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	1.85e-05	0.000619	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	1.84e-05	0.000616	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.82e-05	0.000609	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	1.82e-05	0.000608	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	1.81e-05	0.000607	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	1.81e-05	0.000606	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	1.8e-05	0.000602	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTAFR—polycystic ovary syndrome	1.8e-05	0.000602	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	1.75e-05	0.000584	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	1.73e-05	0.000577	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	1.71e-05	0.000572	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	1.71e-05	0.000572	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—INHBB—polycystic ovary syndrome	1.66e-05	0.000554	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	1.65e-05	0.000551	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	1.61e-05	0.000538	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	1.6e-05	0.000535	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	1.55e-05	0.000519	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	1.55e-05	0.000517	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	1.51e-05	0.000505	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	1.51e-05	0.000504	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	1.47e-05	0.000492	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FSHR—polycystic ovary syndrome	1.41e-05	0.000471	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—POMC—polycystic ovary syndrome	1.38e-05	0.000461	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	1.37e-05	0.000459	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	1.37e-05	0.000458	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	1.34e-05	0.000448	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.33e-05	0.000443	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	1.29e-05	0.000431	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FST—polycystic ovary syndrome	1.26e-05	0.00042	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	1.25e-05	0.000418	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	1.25e-05	0.000417	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.24e-05	0.000415	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LHB—polycystic ovary syndrome	1.23e-05	0.00041	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	1.23e-05	0.00041	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	1.22e-05	0.000407	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.2e-05	0.0004	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.18e-05	0.000393	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.16e-05	0.000388	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.16e-05	0.000387	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SCT—polycystic ovary syndrome	1.15e-05	0.000384	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.13e-05	0.000379	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	1.12e-05	0.000373	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	1.11e-05	0.000371	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.1e-05	0.000368	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.1e-05	0.000366	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	1.09e-05	0.000364	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGF18—polycystic ovary syndrome	1.08e-05	0.00036	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—RBP4—polycystic ovary syndrome	1.07e-05	0.000357	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.06e-05	0.000356	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.06e-05	0.000355	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.05e-05	0.000351	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.03e-05	0.000345	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.03e-05	0.000344	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	1.02e-05	0.000341	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.01e-05	0.000337	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	9.97e-06	0.000333	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	9.84e-06	0.000329	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	9.74e-06	0.000325	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	9.57e-06	0.00032	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	9.49e-06	0.000317	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	9.45e-06	0.000316	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	9.4e-06	0.000314	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	9.34e-06	0.000312	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	8.94e-06	0.000299	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	8.86e-06	0.000296	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	8.8e-06	0.000294	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	8.74e-06	0.000292	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	8.71e-06	0.000291	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	8.35e-06	0.000279	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	8.1e-06	0.000271	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	8.1e-06	0.000271	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	7.94e-06	0.000265	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	7.81e-06	0.000261	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	7.8e-06	0.000261	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	7.73e-06	0.000258	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	7.72e-06	0.000258	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.53e-06	0.000252	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	7.5e-06	0.00025	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	7.19e-06	0.00024	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	7.19e-06	0.00024	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	7.13e-06	0.000238	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	7.08e-06	0.000237	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	7.06e-06	0.000236	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	6.93e-06	0.000231	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	6.86e-06	0.000229	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.81e-06	0.000227	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.7e-06	0.000224	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.69e-06	0.000224	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	6.66e-06	0.000223	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	6.33e-06	0.000212	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	6.29e-06	0.00021	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	6.27e-06	0.00021	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	6.21e-06	0.000208	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.05e-06	0.000202	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.95e-06	0.000199	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.92e-06	0.000198	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	5.81e-06	0.000194	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	5.52e-06	0.000184	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.26e-06	0.000176	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	5.16e-06	0.000172	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.98e-06	0.000166	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	4.87e-06	0.000163	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	4.42e-06	0.000148	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	4.34e-06	0.000145	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	4.33e-06	0.000145	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	4.18e-06	0.00014	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	4.16e-06	0.000139	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	4.02e-06	0.000134	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	4.02e-06	0.000134	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.86e-06	0.000129	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.82e-06	0.000128	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	3.72e-06	0.000124	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	3.7e-06	0.000123	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	3.57e-06	0.000119	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	3.57e-06	0.000119	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.39e-06	0.000113	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	3.08e-06	0.000103	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.73e-06	9.13e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.63e-06	8.78e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.33e-06	7.8e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.82e-06	6.08e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.61e-06	5.4e-05	CbGpPWpGaD
